Allergan's most recent trend suggests a bearish bias. One trading opportunity on Allergan is a Bear Call Spread using a strike $237.50 short call and a strike $242.50 long call offers a potential 42.86% return on risk over the next 29 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $237.50 by expiration. The full premium credit of $1.50 would be kept by the premium seller. The risk of $3.50 would be incurred if the stock rose above the $242.50 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Allergan is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Allergan is bearish.
The RSI indicator is below 20 which suggests that the stock is in oversold territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Allergan
Corporate Share Repurchases Decline for 2nd Year in a Row
Wed, 22 Mar 2017 22:45:06 GMT
Allergan, Dow's Apple Lead Q4 Buybacks; Health Care Atop S&P 500
Wed, 22 Mar 2017 20:35:01 GMT
Allergan Stock Reacts Well In Downtrodden Sector
Wed, 22 Mar 2017 18:52:00 GMT
Latest Editas research pact could be worth up to $1 billion
Wed, 22 Mar 2017 14:30:13 GMT
7:32 am Allergan announces the availability of RESTASIS MULTIDOSE; the first and only prescription medication FDA-approved to help patients with a type of Chronic Dry Eye make more of their own tears
Wed, 22 Mar 2017 11:32:00 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook